These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 36847423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
    Cho J, Shen L, Huq M, Kandane-Rathnayake R, Golder V, Louthrenoo W, Chen YH, Hamijoyo L, Luo SF, Wu YJ, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Navarra SV, Lau CS, Hoi A, Morand EF, Nikpour M, Lateef A, Asia-Pacific Lupus Collaboration.
    Lancet Rheumatol; 2023 Oct; 5(10):e584-e593. PubMed ID: 38251484
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
    Inês L, Duarte C, Silva RS, Teixeira AS, Fonseca FP, da Silva JA.
    Rheumatology (Oxford); 2014 Jan; 53(1):85-9. PubMed ID: 24067885
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity.
    Sun F, Zhao L, Wang H, Zhang D, Chen J, Wang X, Li T, Ye S.
    Lupus Sci Med; 2022 May; 9(1):. PubMed ID: 35606018
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
    Nikoloudaki M, Nikolopoulos D, Koutsoviti S, Flouri I, Kapsala N, Repa A, Katsimbri P, Theotikos E, Pitsigavdaki S, Pateromichelaki K, Bertsias A, Elezoglou A, Sidiropoulos P, Fanouriakis A, Boumpas D, Bertsias G.
    Front Immunol; 2022 May; 13():1074044. PubMed ID: 36685524
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
    Zen M, Saccon F, Gatto M, Montesso G, Larosa M, Benvenuti F, Iaccarino L, Doria A.
    Rheumatology (Oxford); 2020 Jul 01; 59(7):1591-1598. PubMed ID: 31642908
    [Abstract] [Full Text] [Related]

  • 13. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
    Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.
    Clin Exp Rheumatol; 2012 Jul 01; 30(6):856-63. PubMed ID: 22765883
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
    Pawlak-Buś K, Schmidt W, Leszczyński P.
    Eur Rev Med Pharmacol Sci; 2023 Feb 01; 27(3):949-959. PubMed ID: 36808341
    [Abstract] [Full Text] [Related]

  • 16. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.
    Ann Rheum Dis; 2018 Jan 01; 77(1):104-110. PubMed ID: 28970217
    [Abstract] [Full Text] [Related]

  • 17. Steroid-free remission in lupus: myth or reality; an observational study from a tertiary referral centre.
    Goswami RP, Sit H, Ghosh P, Sircar G, Ghosh A.
    Clin Rheumatol; 2019 Apr 01; 38(4):1089-1097. PubMed ID: 30523554
    [Abstract] [Full Text] [Related]

  • 18. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
    Gatto M, Saccon F, Zen M, Regola F, Fredi M, Andreoli L, Tincani A, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo E, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Puppo F, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Mathieu A, Scarpato S, Rossi FW, de Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Larosa M, Iaccarino L, Doria A.
    Arthritis Rheumatol; 2020 Aug 01; 72(8):1314-1324. PubMed ID: 32275125
    [Abstract] [Full Text] [Related]

  • 19. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
    de Luca Montes RA, Huq M, Godfrey T, Oon S, Calderone A, Kandane-Rathnayake R, Louthrenoo W, Luo SF, Jan Wu YJ, Golder V, Lateef A, Navarra SV, Zamora L, Hamijoyo L, Sockalingam S, An Y, Li Z, Katsumata Y, Harigai M, Chan M, Goldblatt F, O'Neill S, Lau CS, Cho J, Hoi A, Karyekar CS, Morand EF, Nikpour M.
    Adv Rheumatol; 2024 May 08; 64(1):38. PubMed ID: 38720354
    [Abstract] [Full Text] [Related]

  • 20. Flares in Chinese systemic lupus erythematosus patients: a 6-year follow-up study.
    Peng L, Wang Z, Li M, Wang Y, Xu D, Wang Q, Zhang S, Zhao J, Tian X, Zeng X.
    Clin Rheumatol; 2017 Dec 08; 36(12):2727-2732. PubMed ID: 28929239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.